drug · small molecule
seltorexant
Phase 3updated 3mo agoby $JNJ JOHNSON & JOHNSON🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
indications
indications
Major Depression
targets
Orexin receptor type 2
all catalysts(0)
nothing on the calendar yet
Trials studying seltorexant
- phase3Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- phase3A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
- phase3A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- phase3A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
- phase3A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
- phase1A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants
- phase1A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants
- phase1A Study of JNJ-42847922 (Seltorexant) in Healthy Participants
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that